Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Barrier Renew is a line of dermatological skincare products developed by SkinMedica (an AbbVie company) designed to support and restore the skin's natural moisture barrier. The regimen typically includes a cleanser and a PM moisturizer, often used in conjunction with sun protection. These products are formulated with ingredients like ceramides and botanical extracts to address skin sensitivity and facial redness. Clinical studies, such as those led by researchers at Cosmetic Laser Dermatology, have evaluated the efficacy of this regimen in reducing mild to moderate facial redness and improving skin barrier function. The products are categorized as cosmeceuticals, intended for topical application to manage skin conditions like erythema and barrier dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Barrier Renew (SkinMedica).